Eye adnexa disorder
MONDO:0000462A disease involving the ocular adnexa.
Also known as: disease of ocular adnexa, disease or disorder of ocular adnexa, disorder of ocular adnexa, ocular adnexa disease, ocular adnexa disease or disorder
519 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
New gel takes on pink eye in Head-to-Head trial
⭐️ CURE ⭐️ CompletedThis study tested a new gel called IVIEW 1201 against standard antibiotic eye drops for treating bacterial pink eye. 129 people with acute bacterial conjunctivitis took part. The goal was to see if the gel works better at clearing up redness and discharge by day 8 and day 14.
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 08:01 UTC
-
New shot for bulging eyes shows promise in early trial
Disease control CompletedThis study tested a new drug called VRDN-003 in 87 people with thyroid eye disease (TED). The drug is given as a shot under the skin and targets a protein linked to the disease. The main goal was to check safety and how the drug moves through the body, not yet to measure how well…
Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New eye drops aim to soothe stubborn dry eye
Disease control CompletedThis study tested cyclosporin 0.1% eye drops in 25 adults with moderate to severe dry eye disease that didn't get better with artificial tears. The goal was to see if the drops reduce eye dryness and redness. Participants used the drops alongside their usual tear substitutes for …
Sponsor: Laboratoires Thea • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Lab-grown stem cells may restore damaged eye surfaces
Disease control CompletedThis study tests whether a graft made from a patient's own or donor stem cells can repair the cornea's surface in people with limbal stem cell deficiency, a condition that causes pain, scarring, and vision loss. A small biopsy of limbal tissue is taken from a healthy eye or donor…
Phase: NA • Sponsor: Veerle Van Gerwen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New eye drops aim to tame pterygium redness
Disease control CompletedThis study tested an eye drop called RMP-A03 in 77 healthy volunteers and people with pterygium, a fleshy growth on the eye. The goal was to see if it safely reduces redness and controls the condition. Participants received either a low dose, high dose, or placebo drops, and rese…
Phase: PHASE2 • Sponsor: Suzhou Raymon Pharmaceuticals Company, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for thyroid eye disease: drug shows promise in Steroid-Resistant patients
Disease control CompletedThis study looked at whether tocilizumab, a drug that calms the immune system, can help people with active moderate-to-severe thyroid eye disease that did not get better with steroids. Thirty-two adults received the drug every four weeks. Researchers measured improvements in eye …
Sponsor: Medical University of Warsaw • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
3D-Printed guides could make thyroid eye surgery safer
Disease control CompletedThis study tested whether using 3D-printed, custom models to plan and guide orbital decompression surgery leads to fewer complications and better outcomes for people with thyroid eye disease. Twelve adults with inactive, moderate-to-severe disease were randomly assigned to receiv…
Phase: NA • Sponsor: Althaia Xarxa Assistencial Universitària de Manresa • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug shows promise for Sjögren's syndrome in early trial
Disease control CompletedThis phase 2 trial tested a biologic drug called RC18 in 42 people with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. Participants received weekly injections of either RC18 (at 160 mg or 240 mg) or a placebo for 24 weeks. The goal was to see if…
Phase: PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug shows promise for Sjögren's syndrome in Mid-Stage trial
Disease control CompletedThis Phase 2 trial tested a drug called CFZ533 (iscalimab) in 273 adults with Sjögren's syndrome, an autoimmune disease causing dryness, pain, and fatigue. Participants received either the drug or a placebo for 24 weeks. The study measured changes in disease activity and symptoms…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis study tested a drug called IBI311 in 91 adults with thyroid eye disease, a condition that can cause bulging eyes and discomfort. Participants received an initial high dose followed by several maintenance doses every three weeks. The main goal was to see if the drug could red…
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Second chance: new drug offers hope for thyroid eye disease Non-Responders
Disease control CompletedThis study tested an investigational drug called VRDN-001 in 143 people with thyroid eye disease who did not improve in earlier studies. The drug aims to reduce inflammation and eye bulging by blocking a specific receptor. Researchers measured how many participants had at least a…
Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis completed Phase 3 trial tested a drug called VRDN-001 in 231 people with thyroid eye disease (TED). The drug works by blocking a receptor involved in inflammation and swelling. The main goal was to check safety and tolerability, with secondary goals including measuring chang…
Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Can your own blood or umbilical cord blood ease dry eyes?
Disease control CompletedThis study tested whether eye drops made from a patient's own blood or from donated umbilical cord blood can improve dry eye disease. Eighty adults with dry eye from conditions like Sjogren's syndrome or after using glaucoma drops were randomly assigned to one of the two types of…
Phase: PHASE1, PHASE2 • Sponsor: G.Gennimatas General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Could an antibiotic beat eye cancer? new trial tests doxycycline for lymphoma
Disease control CompletedThis phase 2 trial tested the antibiotic doxycycline as a first treatment for a rare type of eye lymphoma (OAMZL) that may be linked to a bacterial infection. 44 newly diagnosed patients took doxycycline for several months. The goal was to see if eradicating the infection could c…
Phase: PHASE2 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New eyedrop shows promise for pink eye in small trial
Disease control CompletedThis study tested a new anti-infective eyedrop called SCH1 in 30 adults with acute infectious conjunctivitis (pink eye). Participants received either the active eyedrop or a placebo. The goal was to see if the drug could completely clear redness and discharge. The trial is comple…
Phase: PHASE2 • Sponsor: Sacsh • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Supercharged immune cells take on tough melanoma
Disease control CompletedThis early-phase trial tested a new personalized therapy called TBio-4101 for people with advanced melanoma that had stopped responding to standard treatments. The therapy uses a patient's own tumor-fighting immune cells, which are collected, multiplied in the lab, and then infus…
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug batoclimab aims to reduce eye bulging in thyroid eye disease
Disease control CompletedThis Phase 3 trial tested whether batoclimab, an injected antibody, can reduce eye bulging (proptosis) in people with active, moderate-to-severe thyroid eye disease. 86 participants received weekly injections of batoclimab or a placebo for 24 weeks. The main goal was to see how m…
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New eye drops aim to restore natural moisture in dry eyes
Disease control CompletedThis study tested whether a new eye drop called AR-15512 can improve the health of the eye surface in people with dry eye disease. 80 participants received either the new drops or artificial tears. The main goal was to see if the drops increased the number of goblet cells, which …
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New antibody shows promise for tough thyroid eye disease
Disease control CompletedThis study tested a drug called IBI311 in 53 people with thyroid eye disease that did not get better with steroids. The drug is a modified antibody that blocks a specific receptor. The main goal was to see if it could reduce eye bulging. The trial was completed and compared IBI31…
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Eye drop may prevent eyelash regrowth after trachoma surgery
Disease control CompletedThis study tested whether a steroid eye drop (fluorometholone) given for four weeks after trachoma surgery could stop eyelashes from growing back and rubbing against the eye. Over 2,400 people aged 15 and older took part. The goal was to see if this simple, low-cost addition to s…
Phase: PHASE3 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a rheumatoid arthritis drug ease Sjogren's symptoms?
Disease control CompletedThis study tested whether baricitinib, a drug already used for rheumatoid arthritis, can help people with active Sjogren's syndrome. 87 participants were randomly assigned to receive either hydroxychloroquine alone or baricitinib plus hydroxychloroquine for 24 weeks. The goal was…
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis study tested a new medicine called LASN01 in 41 adults with thyroid eye disease, a condition that causes eye bulging and discomfort. The goal was to see if LASN01 could safely reduce eye bulging compared to a placebo. Participants received either LASN01 or a dummy treatment …
Phase: PHASE2 • Sponsor: Lassen Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Eyelid wipes zap Mite-Caused eye inflammation in new study
Disease control CompletedThis study tested whether cleaning the eyelids with wipes containing chlorhexidine can treat blepharitis caused by Demodex mites. 106 adults with the condition used the wipes twice daily for four weeks. Researchers measured mite counts and eyelash debris before and after treatmen…
Phase: PHASE4 • Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Sjögren's drug shows promise in safety extension trial
Disease control CompletedThis study looked at the long-term safety of efgartigimod in 24 adults with primary Sjögren's syndrome who had already completed a prior trial. Efgartigimod works by lowering certain antibodies that may drive the disease. The main goal was to track side effects over 48 weeks, wit…
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New Sjögren's drug shows promise in small study
Disease control CompletedThis study tested a drug called ianalumab in 21 adults with Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. The goal was to understand how the drug works in the salivary glands and check its safety. Participants received injections of ianalumab and had b…
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Could a new drug combo beat elephantiasis?
Disease control CompletedThis study tested whether a drug called moxidectin, combined with other medicines, works better than the standard treatment (ivermectin combinations) for lymphatic filariasis, a parasitic disease that can cause severe swelling. 164 adults with the infection received a single dose…
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Mass deworming experiment aims to wipe out parasitic worms in three countries
Disease control CompletedThis massive study tested whether giving deworming medicine (albendazole) to everyone in a community, not just children, can break the cycle of soil-transmitted worm infections. Over 350,000 people in India, Malawi, and Benin took part. The goal was to see if treating entire vill…
Phase: PHASE3 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could an arthritis drug ease Sjögren's symptoms?
Disease control CompletedThis study tested whether tocilizumab, a drug that blocks inflammation, can help people with primary Sjögren's syndrome—an autoimmune disease causing dry eyes, dry mouth, pain, and fatigue. Researchers gave 110 participants either tocilizumab or a placebo to see if it could reduc…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Strasbourg, France • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New study explores shorter teprotumumab courses for thyroid eye disease
Disease control CompletedThis study looked at how safe and tolerable different lengths of treatment with teprotumumab are for adults with thyroid eye disease (TED). About 313 participants received the drug for varying durations to see if shorter treatment works as well and reduces side effects. The goal …
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could an eye injection ease thyroid eye disease? small trial tests safety
Disease control CompletedThis Phase 2 trial tested whether injections of aflibercept, a drug that blocks abnormal blood vessel growth, are safe for people with active thyroid eye disease. Eleven adults received three injections over a month, with or without hyaluronidase to help spread the drug. The main…
Phase: PHASE2 • Sponsor: Massachusetts Eye and Ear Infirmary • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis Phase 3 trial tested a drug called batoclimab in 114 adults with active, moderate-to-severe thyroid eye disease (TED). Participants received weekly injections of batoclimab or a placebo for 24 weeks. The main goal was to see if the drug could reduce eye bulging (proptosis) b…
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can flu shots protect autoimmune patients?
Disease control CompletedThis study looked at how well flu vaccines (seasonal and H1N1) work in 234 adults with autoimmune diseases like lupus or vasculitis, some of whom were on steroids or immunosuppressants. Researchers measured antibody levels three weeks after each shot to see if the vaccine provide…
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New light therapy combo aims to soothe dry eyes
Disease control CompletedThis study tested whether low-level light therapy (LLLT) plus non-steroidal immunosuppressant eye drops can help people with dry eye disease. 160 participants received three weekly light sessions along with either cyclosporine or tacrolimus drops. The goal was to see if the combi…
Phase: EARLY_PHASE1 • Sponsor: University of Seville • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New drug shows promise for Sjogren's sufferers
Disease control CompletedThis study tested an experimental drug called nipocalimab in 163 adults with primary Sjogren's syndrome, an autoimmune disease causing dryness and fatigue. Participants received either the drug or a placebo for 24 weeks. The goal was to see if nipocalimab could reduce overall dis…
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New antibody drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis Phase 3 trial tested an investigational drug called veligrotug (VRDN-001) in 188 people with chronic thyroid eye disease. The drug is an antibody that blocks a protein involved in the disease. The main goal was to see if it could reduce eye bulging (proptosis) compared to a …
Phase: PHASE3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Sjögren's drug iscalimab shows promise in safety extension trial
Disease control CompletedThis extension study tested the safety and tolerability of two doses of iscalimab in 206 people with Sjögren's syndrome who had already completed a prior study. Participants received weekly injections for three weeks, then bi-weekly doses. The goal was to see if the drug is safe …
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New eye gel shows promise against stubborn pink eye
Disease control CompletedThis study tested a new eye gel called IVIEW-1201 in 135 people with acute adenoviral conjunctivitis (pink eye caused by a virus). The goal was to see if the gel could clear symptoms like redness and discharge faster than a placebo. The gel contains povidone-iodine, an antiseptic…
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug shows promise for Sjögren's syndrome in early trial
Disease control CompletedThis Phase 2 study tested an experimental drug called SAR441344 in 84 adults with primary Sjögren's syndrome, a condition causing dry eyes, dry mouth, and fatigue. Participants received either the drug or a placebo by injection over 12 weeks. The goal was to see if the drug could…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New biologic IBI311 shows promise for thyroid eye disease in early trial
Disease control CompletedThis Phase II study tested a new biologic drug called IBI311 in 38 people with thyroid eye disease, a condition that causes eye bulging and discomfort. Participants received different doses of the drug to see if it could safely reduce eye protrusion. The trial is completed, and r…
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New eyedrop shows promise for Mite-Related dry eye
Disease control CompletedThis study tested an eyedrop called TP-03 in 39 people with meibomian gland dysfunction (a common cause of dry eye) linked to Demodex mites. The goal was to compare two dosing schedules (twice vs. three times daily) for safety and effectiveness. The results could lead to a new tr…
Phase: PHASE2 • Sponsor: Tarsus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug shows promise for Sjogren's sufferers in major trial
Disease control CompletedThis study tested a drug called telitacicept in 381 adults with active primary Sjogren's syndrome, an autoimmune disease causing dry eyes and mouth. Participants received either the drug or a placebo to see if it safely reduces disease activity. The goal is to control the conditi…
Phase: PHASE3 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New Sjögren's drug IBI355 enters human testing
Disease control CompletedThis early-stage trial tests an experimental drug called IBI355 in 30 adults with primary Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. The main goal is to check the drug's safety and how the body processes it at different doses. Participants receive e…
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:11 UTC
-
Teprotumumab shows promise in small chinese thyroid eye study
Disease control CompletedThis completed study looked at how well teprotumumab (TEPEZZA) works in real-world use for 5 Chinese patients with thyroid eye disease. The main goal was to see how many patients had a reduction in eye bulging (proptosis) after their last IV infusion. The study also collected bas…
Sponsor: Amgen • Aim: Disease control
Last updated Jun 26, 2026 14:37 UTC
-
New imaging tool may help detect Eye-Area skin cancer without a biopsy
Diagnosis CompletedThis study tested a non-invasive imaging device called dermal optical coherence tomography (D-OCT) to diagnose basal cell carcinoma (a common skin cancer) around the eye area. Researchers compared its accuracy to standard biopsy results in 210 adults with suspected lesions. The g…
Sponsor: Vejle Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:37 UTC
-
AI reads biopsies to spot Sjogren's syndrome
Diagnosis CompletedThis study tested an artificial intelligence (AI) algorithm designed to analyze images of minor salivary gland biopsies to help diagnose Sjogren's syndrome. Researchers used 1,000 biopsy samples from patients with suspected Sjogren's to see if the AI could accurately count immune…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Diagnosis
Last updated Jun 27, 2026 12:26 UTC
-
Two-Minute sweat test could spot hidden nerve damage
Diagnosis CompletedThis study tested a device called SUDOSCAN, which measures sweat function in just two minutes, to see if it can detect small fiber nerve damage in people with autoimmune diseases (like lupus or rheumatoid arthritis) or unexplained pain. Researchers enrolled 139 adults and compare…
Phase: NA • Sponsor: Hôpital Européen Marseille • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New screen mode may keep your eyes fresh longer
Prevention CompletedThis study tested whether a new dynamic color temperature mode on screens can prevent dry eye and visual fatigue. Thirty adults read text on a screen for 50 minutes under different color settings. Researchers measured eye fatigue and dryness before and after to see if the new mod…
Phase: NA • Sponsor: Beijing Tongren Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Lupus drug hydroxychloroquine tested as COVID-19 shield
Prevention CompletedThis completed study looked at whether lupus patients already taking hydroxychloroquine long-term had a lower risk of catching COVID-19 or developing severe symptoms. Researchers compared 552 patients who either took the drug or did not, using blood tests and questionnaires. The …
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis Phase 3 trial tested rebamipide eye drops in 762 people with dry eye lasting at least 6 months. Participants received either rebamipide or placebo drops for 26 weeks. The goal was to see if the drops could reduce eye surface damage and discomfort better than placebo.
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Eye insert could ease allergy symptoms for contact lens wearers
Symptom relief CompletedThis early study tested a dexamethasone eye insert placed by a doctor against a standard steroid gel for treating allergy and dry eye symptoms in 36 people with keratoconus who wear gas permeable contact lenses. The goal was to see if the insert improves signs like eyelid bumps a…
Phase: EARLY_PHASE1 • Sponsor: Illinois College of Optometry • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Eye drops bring relief to dry eye sufferers
Symptom relief CompletedThis study tested whether using Systane PRO eye drops consistently for 30 days can relieve symptoms of dry eye disease and improve daily functioning. Thirty-three adults with mild to moderate dry eye took part. The main goal was to see if their eye comfort scores improved from th…
Phase: PHASE4 • Sponsor: Gordon Schanzlin New Vision • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis Phase 3 trial tested rebamipide eye drops in 755 people with dry eye for at least 6 months. Participants received either rebamipide or placebo drops for up to 52 weeks. The goal was to see if the drops could reduce eye surface damage and ease discomfort.
Phase: PHASE3 • Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New eye drop aims to soothe dry, irritated eyes
Symptom relief CompletedThis study tests an experimental eye drop called GRF312 5% in 100 adults with dry eye disease. The goal is to see if it is safe and helps relieve symptoms. Participants will use the drops at home and attend clinic visits for check-ups.
Phase: PHASE2 • Sponsor: Instituto Grifols, S.A. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could a simple nerve stimulator ease chronic eye pain?
Symptom relief CompletedThis pilot study tested whether a TENS device, placed on the forehead, is safe and practical for treating chronic eye pain in 39 veterans. Participants used the device at home for 6 months. The goal was to see if it reduces pain and to prepare for a larger trial.
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New eye drops aim to soothe dry eyes – first human test underway
Symptom relief CompletedThis early study tests whether RCI001 eye drops are safe and tolerable in 40 healthy adult men. Participants receive either the active eye drops or a placebo, and researchers monitor for side effects and how the drug behaves in the body. This is a first step toward possibly devel…
Phase: PHASE1 • Sponsor: Rudacure • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New eye drops aim to soothe dry eye in bone marrow transplant patients
Symptom relief CompletedThis study tested whether CAM-101 eye drops are safe and can help relieve dry eye in people who developed the condition after a bone marrow transplant (graft-versus-host disease). 64 adults received either a low or high dose of CAM-101 or a placebo drop four times a day for six w…
Phase: PHASE1, PHASE2 • Sponsor: Cambium Bio Limited • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Supplement shows promise for dry eye sufferers in new study
Symptom relief CompletedThis study tested whether a dietary supplement called Nutritears, containing lutein, zeaxanthin, curcuminoids, and vitamin D3, can improve dry eye symptoms. 131 adults with dry eye syndrome took either the supplement or a placebo daily for 8 weeks. Researchers measured tear produ…
Phase: NA • Sponsor: Applied Science & Performance Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Warm eyelid treatment for dry eye gets a boost?
Symptom relief CompletedThis study tested the TearCare MGX system, a device that applies heat to the eyelids, for treating dry eye caused by meibomian gland dysfunction. 21 adults with dry eye symptoms received the treatment, comparing a standard version with one that includes an extended warming hold. …
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
USB-Powered eye mask beats disposable pads for dry eyes
Symptom relief CompletedThis study tested two ways to warm the eyelids for people with dry eyes caused by meibomian gland dysfunction. Fifteen adults used a USB-powered warm compress and a self-heating eye mask for two weeks each. Both devices improved tear stability and comfort, but the USB-powered ver…
Phase: NA • Sponsor: King Saud University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Eye redness drops show promise in large trial
Symptom relief CompletedThis completed Phase 3 trial tested a new eye drop containing brimonidine and sodium hyaluronate against Lumify for reducing eye redness in 578 adults. Participants used the drops four times daily, and redness was measured over several hours. The goal was to see if the new drop w…
Phase: PHASE3 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Which eye drop stings less? small study pits flarex against lotemax SM
Symptom relief CompletedThis study tested how comfortable two prescription steroid eye drops feel right after use. Forty adults with eye inflammation or dry eye received one drop of Flarex in one eye and one drop of Lotemax SM in the other. They rated comfort and vision impact at 30 seconds, 5 minutes, …
Phase: PHASE4 • Sponsor: Harrow Inc • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
Warm compress device shows promise for dry eyes before cataract surgery
Symptom relief CompletedThis study tested whether using the Systane iLux device—which applies heat and pressure to the eyelids—before cataract surgery could improve dry eye symptoms. Thirty adults scheduled for cataract surgery received the treatment in one eye. Researchers measured changes in tear film…
Phase: NA • Sponsor: George Washington University • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New eye drops zap allergy itch in just minutes
Symptom relief CompletedThis study tested an eye drop called reproxalap in 131 adults with moderate-to-severe seasonal eye allergies. Participants were exposed to ragweed pollen in a special chamber to trigger symptoms. The eye drop was compared to a placebo (no active ingredient) to see if it reduced i…
Phase: PHASE3 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New drug could soothe cat allergy eyes
Symptom relief CompletedThis study tested two experimental drugs, REGN1908 and REGN1909, mixed together to reduce eye allergy signs and symptoms in people with cat allergies. The goal was to see how safe and effective the drug is compared to a placebo. The study included 64 participants with a history o…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Wheat-Free diet shows promise for Sjogren's sufferers in small study
Symptom relief CompletedThis pilot study tested whether a wheat-free and milk-free diet could reduce symptoms in people with Sjogren's syndrome, an autoimmune disease. Thirty participants were randomly assigned to either the special diet or a control diet. After two months, those on the wheat-free diet …
Phase: NA • Sponsor: University of Palermo • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a nasal spray soothe dry eyes?
Symptom relief CompletedThis study tested whether a nasal spray containing varenicline (OC-01) can improve tear film quality and reduce dryness in people with dry eye disease. Fifty adults used either the active spray or a placebo. Researchers measured tear film changes and symptom scores shortly after …
Phase: PHASE4 • Sponsor: Stephenson Eye Associates • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Acupuncture with a jolt: new hope for dry eyes?
Symptom relief CompletedThis study tested whether electroacupuncture (a type of acupuncture with mild electric pulses) can improve symptoms of mild-to-moderate dry eye. 168 adults received either real or sham electroacupuncture. Researchers measured tear film stability and other eye health markers to se…
Phase: NA • Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis study tested whether BRM421 eye drops can safely reduce the signs and symptoms of dry eye compared to a placebo. 220 adults with dry eye for at least 6 months received either the active drops or a placebo. The main outcomes were changes in corneal staining (eye surface damag…
Phase: PHASE2, PHASE3 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New eye drop shows promise for dry eye sufferers
Symptom relief CompletedThis study tested whether BRM421 eye drops can safely ease the signs and symptoms of dry eye. 157 adults with dry eye for at least 6 months received either the active drops or a placebo. The trial measured changes in corneal staining and discomfort scores. Results suggest the dro…
Phase: PHASE2 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Warm eye masks show promise for dry eye sufferers
Symptom relief CompletedThis study tested whether far infrared eye masks placed on acupoints around the eyes could improve dry eye symptoms. Thirty-one adults with dry eye disease used the masks, and researchers measured tear film stability, gland health, and symptom scores before and after one month of…
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New eye drop offers hope for dry eye sufferers
Symptom relief CompletedThis study tested an eye drop called HBM9036 in 577 Chinese adults with moderate to severe dry eye. The goal was to see if it reduces eye surface damage and improves symptoms better than a placebo. Participants used the drops for about two months, and doctors measured changes in …
Phase: PHASE3 • Sponsor: Harbour BioMed (Guangzhou) Co. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New eyedrops aim to soothe dry, irritated eyes
Symptom relief CompletedThis early-stage trial tested an experimental eyedrop called INV-102 in 84 adults with moderate dry eye disease. The study had two parts: first, checking safety at different doses, and second, seeing if the drops improve eye dryness symptoms after two weeks. Participants used the…
Phase: PHASE1, PHASE2 • Sponsor: Invirsa, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
New drug cocktail aims to stop itchy eyes from birch pollen
Symptom relief CompletedThis study tested two experimental drugs, REGN5713 and REGN5715, given together to reduce eye allergy symptoms caused by birch pollen. Fifty-four adults with a history of moderate to severe birch pollen allergy received the drug combo or a placebo. The main goal was to see if the…
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Special contact lenses aim to soothe dry eyes
Symptom relief CompletedThis study tested whether scleral lenses treated with a special coating called Hydra-PEG can improve comfort and reduce dryness in people with dry eye. 46 participants wore two types of lenses over several weeks and rated their comfort on a scale. The goal was to see if the coate…
Phase: NA • Sponsor: CooperVision International Limited (CVIL) • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Could a simple eyelid wipe soothe dry eyes?
Symptom relief CompletedThis study tested three ways to use an eyelid wipe soaked with IVW-1001, a dry eye treatment, in 30 people with dry eye disease. Researchers measured changes in tear production and checked for any vision changes. The goal was to find the best wiping technique for safety and sympt…
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Wrinkle-Zapping device may double as dry eye remedy
Symptom relief CompletedThis pilot study tested whether Tixel, a device used to treat wrinkles around the eyes, could also improve dry eye symptoms. 75 adults with mild to moderate wrinkles and dry eye received the standard Tixel treatment. Researchers measured tear film stability and dry eye questionna…
Phase: NA • Sponsor: Aston University • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
New eyelid wipe dosing methods tested for dry eye relief
Symptom relief CompletedThis study tested three different ways to use a medicated eyelid wipe (IVW-1001) for people with dry eye disease. Fifteen adults with dry eye took part. The main goal was to see how safe and tolerable the different dosing techniques were, and how well they improved tear productio…
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Walking away from Sjögren's fatigue: study tests simple exercise
Symptom relief CompletedThis study looked at whether regular aerobic exercise, like walking, can reduce fatigue in women with primary Sjögren's syndrome. Forty-five women participated in a 16-week program. Researchers measured changes in fatigue, mood, and physical fitness.
Phase: NA • Sponsor: Samira Tatiyama Miyamoto, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Warm compresses vs. High-Tech eye gadgets: which best treats dry eye?
Symptom relief CompletedThis study tested three treatments for meibomian gland dysfunction, a common cause of dry eye. 374 adults with mild-to-moderate dry eye were randomly assigned to receive either vectored thermal pulsation (a device that heats and massages the eyelids), intense pulsed light therapy…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New eye drops for dry eye pass safety check in small trial
Symptom relief CompletedThis study tested the safety of AR-15512 eye drops in 55 people with dry eye disease. Participants received the drops at different temperatures and with eyes open or closed to see if these factors affect side effects. The goal was to measure how many people had eye-related side e…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Can a herbal mist soothe dry eyes? new study investigates
Symptom relief CompletedThis study tested whether a fine mist made from traditional Chinese herbs can help people with dry eye disease. 200 adults received either the herbal mist, a placebo mist, or standard eye drops for 4 months. Researchers measured symptom scores and tear film stability to see if th…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Eyelid injection shows promise for thyroid eye disease symptoms
Symptom relief CompletedThis study tested whether injecting triamcinolone acetonide into the eyelid could help people with thyroid eye disease who have a retracted upper eyelid. Fifteen adults received a combination of two injections and were measured one month later. The goal was to see if the eyelid p…
Phase: NA • Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New eye drops show promise for dry eye sufferers
Symptom relief CompletedThis early-phase trial tested YM-101 eye drops in 30 adults with dry eye syndrome. Participants received either high or low dose YM-101 plus artificial tears, then switched to placebo after a washout period. The study measured changes in corneal staining, tear break-up time, and …
Phase: EARLY_PHASE1 • Sponsor: Eye & ENT Hospital of Fudan University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can your own blood soothe dry eyes? new study says maybe.
Symptom relief CompletedThis study tested whether eye drops made from a patient's own blood (autologous serum) can relieve severe dry eye better than standard artificial tears. 46 adults with severe dry eye tried both diluted (20%) and full-strength (100%) serum drops, as well as artificial tears. The m…
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Could insulin eye drops ease dry eye? new trial results
Symptom relief CompletedThis study tested if insulin eye drops can safely and effectively treat moderate to severe dry eye disease. 116 adults received either insulin drops, standard cyclosporin drops, or artificial tears (placebo) for 6 months. The main goal was to see if insulin drops improved corneal…
Phase: PHASE4 • Sponsor: Barbara Burgos Blasco • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New eye drops take on dry eye in Head-to-Head trial
Symptom relief CompletedThis phase 3 trial tested whether a new eye drop called HUC3-053 works as well as an existing drop (Hyalein) for dry eye. 297 adults used the drops 5-6 times daily for 12 weeks. The study measured changes in eye surface staining and other signs of dry eye.
Phase: PHASE3 • Sponsor: Huons Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Yellow screen shields eyes from digital strain, study finds
Symptom relief CompletedThis study tested whether a special yellow-light, anti-glare phone screen could reduce eye strain and dryness caused by using a phone for 2 hours in a dim room. 70 adults with mild nearsightedness took part. Researchers measured tear quality, eye redness, and other signs of eye f…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Can more drops beat dry eye? new study tests three schedules
Symptom relief CompletedThis Phase 2 study tested three different dosing schedules of Lagricel Ofteno eye drops (sodium hyaluronate 0.4%) in 141 people with mild to moderate dry eye. Participants used the drops either twice, four times, or six times a day. The main goal was to see which schedule best im…
Phase: PHASE2 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Eye gel may replace painful needle in pterygium surgery
Symptom relief CompletedThis study tested whether a numbing gel (lidocaine) works as well as a needle injection for pain relief during pterygium surgery. 41 adults having pterygium removal took part. The goal was to see if the gel causes less pain and eye dryness after surgery.
Phase: PHASE4 • Sponsor: Vrije Universiteit Brussel • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Eye drop showdown: which one beats dry eye?
Symptom relief CompletedThis study tested three different eye drops (Humylub Ofteno PF, Hyabak, and Lagricel Ofteno PF) in 182 people with mild to moderate dry eye. Participants used the drops four times a day for 30 days. The main goal was to see if Humylub was as good as the others at reducing dry eye…
Phase: PHASE4 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Gut health hack: supplement shows promise for dry eyes
Symptom relief CompletedThis study tested whether a dietary supplement could improve dry eye symptoms by changing the bacteria in the gut. Twenty adults with dry eye disease took the supplement for 8 weeks. Researchers measured tear production and eye surface health before and after treatment. The goal …
Phase: NA • Sponsor: Varol TUNALI • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New eye drops aim to soothe dry eyes with fewer doses
Symptom relief CompletedThis completed study tested whether Reinnerva/Lubristil+G eye drops work better than Vismed for people with dry eyes. Forty adults with dry eye symptoms used one drop in each eye twice daily (Reinnerva/Lubristil+G) or four times daily (Vismed) for 60 days. Researchers measured te…
Phase: NA • Sponsor: Medivis SRL • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Could these new drops soothe dry eyes?
Symptom relief CompletedThis study tested a new eye drop formula in 188 adults with mild to moderate dry eye disease. Participants used the drops for 30 days and reported how much their symptoms bothered them. The goal was to see if the drops safely improve comfort.
Phase: NA • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis study tested a new eye treatment called TTAX03 in 74 people with mild to moderate dry eye disease. The goal was to see if it is safe and if it can reduce eye dryness and damage. Participants received either a single dose of TTAX03 or a saline (salt water) control and were ch…
Phase: PHASE2 • Sponsor: BioTissue Holdings, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New eye drops aim to soothe dry eyes
Symptom relief CompletedThis phase 2 trial tested two strengths of rhNGF eye drops against a placebo in 317 adults with moderate-to-severe dry eye disease. Participants used the drops three times a day for 4 weeks, followed by 4 weeks of monitoring. The goal was to see if the drops could improve dry eye…
Phase: PHASE2 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
New eyelid wipe aims to soothe dry eyes
Symptom relief CompletedThis study tested a new medicated eyelid wipe called IVW-1001 in 150 adults with dry eye disease. Participants used either a low dose, a higher dose, or a placebo wipe. The goal was to see if the wipe is safe and can improve tear production and eye comfort.
Phase: PHASE1, PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Eye drops Face-Off: which works better for dry eyes during cataract surgery?
Symptom relief CompletedThis study tested two different eye drop treatments for people with dry eye disease who were having cataract surgery. One group used a single medication (rebamipide), while the other used a combination of two medications (diquafosol and cyclosporine). The goal was to see which ap…
Phase: PHASE4 • Sponsor: Samsung Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New eye drops aim to boost tears in dry eye sufferers
Symptom relief CompletedThis completed Phase 3b trial tested AR-15512 eye drops in 81 adults with dry eye disease. The goal was to see if a single dose could quickly increase tear production, measured by tear meniscus height. The study was open-label, meaning everyone knew they were getting the active d…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Shedding light on dry eye: new study tests IPL and LED mask therapies
Symptom relief CompletedThis study looked at how two light-based treatments—intense pulsed light (IPL) and low-level light therapy (LLLT)—work for dry eye disease caused by clogged oil glands. Twenty-six participants received four treatment sessions, with one eye getting IPL plus LLLT and the other gett…
Phase: NA • Sponsor: Aston University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Can ectoin sprays and drops soothe hay fever? new study investigates
Symptom relief CompletedThis study tested whether Ectoin allergy nasal spray and eye drops can relieve symptoms of hay fever (runny nose, sneezing, itchy eyes) better than a placebo. 46 adults with ragweed allergies were exposed to pollen in a special chamber. Researchers measured symptom scores and nas…
Phase: NA • Sponsor: Bitop AG • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New eye drop battle: can ectoin beat hyaluronic acid for dry eyes?
Symptom relief CompletedThis study compared two types of eye drops—ectoin (BAT04) and hyaluronic acid—for treating dry eye disease. 64 adults with mild to moderate dry eye used the drops six times daily in both eyes for 28 days. The main goal was to see how well each drop improved tear film stability, m…
Sponsor: Bitop AG • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New eye drop takes on dry eye in head-to-head trial
Symptom relief CompletedThis study tested whether a new eye drop called T2769 works as well as a commonly used one (Vismed Multi) for people with moderate to severe dry eye. 251 adults used the drops for 35 days. The main goal was to see if T2769 could reduce eye surface damage as effectively as Vismed …
Phase: NA • Sponsor: Laboratoires Thea • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New eye drops aim to zap redness fast in kids and adults
Symptom relief CompletedThis completed Phase 3 trial tested whether FID 123320 eye drops can safely reduce eye redness caused by minor irritations. The study involved 283 children and adults who used either the active drops or a placebo. Researchers measured redness at several time points, from 1 minute…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New eye drop shows promise for dry eye sufferers in Late-Stage trial
Symptom relief CompletedThis Phase 3 trial tested SI-614 eye drops, a modified form of sodium hyaluronate, against placebo in 232 adults with dry eye disease. Participants used the drops four times daily for 84 days. The study measured changes in eye surface staining (a sign of damage) and daily symptom…
Phase: PHASE3 • Sponsor: Seikagaku Corporation • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
New eye gel shows promise for dry eye sufferers
Symptom relief CompletedThis early-stage study tested a new eye gel called PRO-165 to see if it is safe and tolerable for people with dry eyes. 32 healthy adults used either the new gel or a standard lubricating gel. The goal was to check for side effects and comfort, not to cure dry eye.
Phase: PHASE1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Light therapy before laser eye surgery may keep dry eyes away
Symptom relief CompletedThis study tested whether giving two types of light therapy (intense pulsed light and low-level light therapy) before laser eye surgery can help prevent dry eyes afterward. 62 people who were already scheduled for laser vision correction took part. The goal was to see if these tr…
Phase: NA • Sponsor: University Hospital, Brest • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New eye drop shows promise for dry eye sufferers
Symptom relief CompletedThis study tested a single-dose eye drop containing hyaluronate and sodium phosphate to relieve eye discomfort, especially dryness. Twenty-eight adults with mild to moderate dry eye participated. Researchers measured how long tears stayed on the eye and checked eye surface health…
Sponsor: SIFI SpA • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New eye drop T2769 takes on Hylo-Forte in dry eye showdown
Symptom relief CompletedThis study tested whether a new eye drop called T2769 works as well as a standard treatment (Hylo-Forte) for people with moderate to severe dry eye. 74 adults who still had dry eye symptoms despite using artificial tears took part. The main goal was to see if T2769 could reduce e…
Phase: NA • Sponsor: Laboratoires Thea • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Light therapy mask may soothe dry eyes after cataract surgery
Symptom relief CompletedThis study tested a low-level light therapy mask on 98 adults having cataract surgery. The mask was used one week before and one week after surgery to see if it could prevent or reduce dry eye symptoms. Researchers measured dry eye symptoms, tear stability, and eye surface health…
Phase: NA • Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New laser zaps dry eye by targeting blood vessels on eyelids
Symptom relief CompletedThis study tested a gentle laser (micropulse) on 30 people with dry eye from meibomian gland dysfunction. The laser targets tiny blood vessels on the eyelid edge to reduce inflammation and improve tear quality. Researchers measured tear stability and symptom scores to see if the …
Phase: NA • Sponsor: Naval Hospital, Athens • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Which dry eye drop works faster? new study pits diquafosol against rebamipide
Symptom relief CompletedThis study tested two different eye drops—diquafosol and rebamipide—to see which one provides faster relief for dry eye disease. Thirty adults with dry eye received one drop of each, and their symptoms and tear quality were checked 30 minutes later. The goal was to find out which…
Phase: PHASE4 • Sponsor: Korea University Anam Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New eye drops aim to quickly soothe dry eye pain
Symptom relief CompletedThis completed Phase 3 trial tested whether 0.25% reproxalap eye drops can reduce discomfort from dry eye disease better than a placebo. 116 adults with dry eye for at least 6 months used the drops six times over two days. The main goal was to measure changes in eye discomfort us…
Phase: PHASE3 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Can a new eye drop help contact lens wearers beat dry eye?
Symptom relief CompletedThis study tested whether Miebo eye drops (perfluorohexyloctane) can safely and effectively relieve dry eye symptoms in people who wear soft contact lenses. 104 adults used the drops up to four times daily, both before and while wearing their lenses. Researchers measured changes …
Phase: PHASE4 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Mind-Body exercise shows promise for Sjögren's fatigue and pain
Symptom relief CompletedThis study tested a cognitive exercise therapy approach (BETY) in 60 adults with primary Sjögren's syndrome. Participants were randomly assigned to group sessions, individual sessions, or a home exercise program for 12 weeks. The therapy combines physical exercises with strategie…
Phase: NA • Sponsor: Kahramanmaras Sutcu Imam University • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Can a common supplement soothe Sjogren's dry eye?
Symptom relief CompletedThis small study tested whether levocarnitine, a natural substance, can help treat dry eye in adults with Sjogren's syndrome. Fifteen participants received both the drug and a placebo in a crossover design. The goal was to see if levocarnitine reduces eye inflammation and improve…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New contact lens aims to bring back dropouts bothered by dry eyes
Symptom relief CompletedThis study tested whether Total 30 contact lenses can help people who previously stopped wearing contact lenses because of discomfort or dryness. Sixty adults aged 18 to 40 who had worn reusable lenses for at least a year but quit within the past two years were refitted with Tota…
Phase: NA • Sponsor: Southern College of Optometry • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New eye drops for dry eye pass safety check in large trial
Symptom relief CompletedThis study tested the safety of reproxalap eye drops in 757 adults with dry eye disease. Participants used the drops for up to one year. The main goal was to check for serious side effects like vision changes or eye pressure increases. Results will show whether the drops are safe…
Phase: PHASE3 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New eye drops aim to soothe dry eyes in major trial
Symptom relief CompletedThis Phase 3 study tested SJP-0132 eye drops against placebo in 427 Chinese adults with dry eye disease. Participants used the drops four times daily for 8 weeks. The goal was to see if the drops improve eye surface damage and reduce dryness symptoms.
Phase: PHASE3 • Sponsor: Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New eye drops aim to soothe Sjogren's dry eye sufferers
Symptom relief CompletedThis Phase 3 study tested cenegermin (Oxervate) eye drops against a placebo in 85 adults with severe dry eye caused by Sjogren's syndrome, who were already using cyclosporine drops. The goal was to see if cenegermin could increase tear production and reduce eye discomfort over 4 …
Phase: PHASE3 • Sponsor: Dompé Farmaceutici S.p.A • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Warm eyelid treatment could replace daily drops for dry eye sufferers
Symptom relief CompletedThis study tested whether a device that warms and massages the eyelids (TearCare) works better than prescription eye drops (Restasis) for dry eye disease. 345 adults with dry eye and blocked eyelid glands were randomly assigned to either an in-office TearCare procedure or twice-d…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Phone film fights dry eyes and strain in new study
Symptom relief CompletedThis study tested whether special anti-reflection and circularly polarized films placed on smartphone screens can reduce dry eyes and eye strain caused by close-up screen use. 120 adults with mild nearsightedness used phones for 45 minutes in light or dark settings. Researchers m…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New eye drops could bring relief for millions with dry eyes
Symptom relief CompletedThis study tested whether 0.05% cyclosporine eye drops can improve symptoms of mild to moderate dry eye. Researchers enrolled 60 adults and compared the drops to standard artificial tears. The goal was to see if the drops reduce eye inflammation and ease discomfort like tired eye…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Warm eyelid treatment shows promise for dry eye sufferers
Symptom relief CompletedThis study tested the TearCare device, which warms the eyelids to melt clogged oil glands and improve tear quality. Twelve adults who had used the device before received another treatment. Researchers measured how long tears stayed on the eye and checked gland function. The goal …
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Could a radio frequency device ease dry eye?
Symptom relief CompletedThis study tested a radio frequency device (Forma Eye) for dry eye caused by meibomian gland dysfunction. 47 adults received up to 3 treatments and were followed for 24 weeks. Researchers measured symptom scores, tear break-up time, and gland function to see if the treatment is s…
Phase: NA • Sponsor: InMode MD Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New eye drops promise quick redness relief
Symptom relief CompletedThis study tested whether a special eye drop (apraclonidine) can safely reduce eye redness caused by minor irritations. 159 adults who often use redness-relief drops took part. Researchers measured redness before and after using the drops, checking at 15 minutes and 10 hours late…
Phase: PHASE3 • Sponsor: Alcon Research • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New eye drops show promise for fast dry eye relief
Symptom relief CompletedThis study tested Miebo eye drops in 99 adults with dry eye disease. Participants used one drop in each eye four times daily for 14 days. The main goal was to see how much dry eye symptoms improved after one week, measured on a 0-to-100 scale. The study is complete, but results a…
Phase: PHASE4 • Sponsor: Bausch & Lomb Incorporated • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Warm compress rival? TearCare device tested for dry eye
Symptom relief CompletedThis small pilot study tested the TearCare system, a device that applies heat to the eyelids, in 24 adults with dry eye disease. The goal was to see if it safely improves tear stability and oil gland function compared to a warm compress. Results were measured after one month.
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New eye drops aim to soothe dry eyes
Symptom relief CompletedThis Phase 2 trial tested an experimental eye drop called SHJ002 in 85 adults with dry eye disease. The drops are designed to block a specific microRNA linked to inflammation. Researchers measured changes in corneal staining and symptom scores over 84 days to see if the drops are…
Phase: PHASE2 • Sponsor: Dreamhawk Vision Biotech, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New device brings relief to dry eye sufferers
Symptom relief CompletedThis study tested a device called TearCare against another device, LipiFlow, in 235 adults with dry eye disease caused by blocked oil glands. The goal was to see if TearCare safely improves tear quality and eye comfort. Participants received one treatment session, and researchers…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis Phase 3 trial tested whether reproxalap eye drops can safely reduce discomfort in people with dry eye disease. 421 adults used the drops or a placebo for up to 6 weeks. The main goal was to measure changes in eye discomfort scores over time.
Phase: PHASE3 • Sponsor: Aldeyra Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New eye drops aim to soothe dry, red eyes
Symptom relief CompletedThis study tested a new preservative-free eye drop (Thealoz Total) in 30 adults with chronic dry eye and eye redness. Participants used the drops daily for 12 weeks. Researchers measured changes in redness and how satisfied patients felt. The goal was to see if the drops improve …
Sponsor: Laboratoires Thea • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Probiotics pill shows promise for dry eye relief
Symptom relief CompletedThis study tested whether taking a daily probiotic capsule for 35 days can reduce dry eye symptoms in adults aged 20 to 65 with confirmed dry eye. Researchers measured tear production, tear quality, and eye surface health before and after the treatment. The goal was to see if pro…
Phase: NA • Sponsor: Chung Shan Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Ear needles may soothe dry eyes, small study suggests
Symptom relief CompletedThis study tested whether auricular acupuncture (tiny needles on the ear) can relieve dry eye symptoms in university students. Fifty students with dry eyes received either real ear acupuncture or a sham version, plus artificial tears, for four weeks. Researchers measured symptom …
Phase: NA • Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Light therapy eases dry eyes after LASIK, study finds
Symptom relief CompletedThis study tested a gentle light treatment (low-level light therapy) given before and after Femto-LASIK eye surgery. 61 adults without prior dry eye received either real light therapy or a sham treatment. Those who got the real treatment had more stable tears and fewer dry eye sy…
Phase: NA • Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can acupuncture boost dry eye relief? new study tests combo therapy
Symptom relief CompletedThis study tested whether adding acupuncture to standard artificial tears helps people with moderate dry eye more than drops alone. 90 adults were randomly assigned to get either artificial tears only or tears plus acupuncture twice a week for five weeks. Researchers measured sym…
Phase: NA • Sponsor: Nadide Koca • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Warm eyelid treatment shows promise for dry eye sufferers
Symptom relief CompletedThis study tested the TearCare system, a device that gently heats the eyelids for 15 minutes followed by manual expression, in 29 adults with dry eye disease. The goal was to see if a single treatment could improve tear film stability and reduce dry eye symptoms over one month. T…
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 15:56 UTC
-
New eye drop shows promise for allergy itch
Symptom relief CompletedThis phase 2 trial tested whether VSJ-110 eye drops can reduce itching and redness caused by allergic conjunctivitis (eye allergies). 47 adults received either the active eye drop or a placebo, then were exposed to an allergen. The study measured how much their eyes itched and re…
Phase: PHASE2 • Sponsor: Vanda Pharmaceuticals • Aim: Symptom relief
Last updated Jun 26, 2026 15:34 UTC
-
Nose stimulator could be new hope for Sjogren's dry eyes
Symptom relief CompletedThis pilot study tested a device that gently stimulates the inside of the nose to see if it can improve tear production in people with Sjogren's syndrome. 26 participants used either the active device or a sham (fake) device for 6 weeks, then everyone used the active device for a…
Phase: NA • Sponsor: Abilion Medical Systems AB • Aim: Symptom relief
Last updated Jun 26, 2026 12:36 UTC
-
Acne Drug's hidden toll on the eye revealed
Knowledge-focused CompletedThis study looks at how isotretinoin, a vitamin A-based acne medication, affects eye structures and tear production in people with severe cystic acne. Participants receive standard treatment and undergo eye exams, including dry eye tests and advanced imaging, before and during th…
Phase: NA • Sponsor: Demet Mutlu • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Sjögren's muscle mystery: study aims to classify inflammatory involvement
Knowledge-focused CompletedThis study looked at 54 people with primary Sjögren's syndrome who also had muscle inflammation. Researchers wanted to see how many met the official criteria for inflammatory myopathies. The goal was to better understand and classify muscle disease in Sjögren's patients.
Sponsor: University Hospital, Brest • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Surgeons try apple vision pro during cataract operations
Knowledge-focused CompletedThis study tested whether surgeons can safely use an Apple Vision Pro headset to view a microscope during cataract and other eye surgeries. 45 adults having elective eye surgery took part. The goal was to see if the headset is safe and comfortable for the surgeon, not to change h…
Phase: NA • Sponsor: Sharp HealthCare • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Sjögren's syndrome study digs deep into Mind-Body connection
Knowledge-focused CompletedThis study looked at 100 people with primary Sjögren's syndrome to understand how the disease affects their physical, emotional, and social well-being. Researchers used questionnaires and simple tests to measure symptoms like fatigue, pain, swallowing problems, and mood. A health…
Sponsor: Kahramanmaras Sutcu Imam University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Are women with autoimmune diseases getting the gynecological care they need?
Knowledge-focused CompletedThis study examined whether women with autoimmune diseases or inflammatory rheumatism receive proper gynecological follow-up, including cervical cancer screening and contraception advice. Researchers surveyed 318 women with conditions like lupus, rheumatoid arthritis, and Sjögren…
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Artificial eye users may face hidden dry eye damage
Knowledge-focused CompletedThis study looked at 20 adults who wear an artificial eye to see if it causes more dry eye symptoms and damage to the tiny oil glands in the eyelids. Researchers compared the artificial eye side with the healthy eye side using special imaging and questionnaires. The goal was to u…
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Filtering serum eye drops: does it remove key healing molecules?
Knowledge-focused CompletedThis study involved 10 adults with severe dry eye disease who did not respond to standard treatments. Researchers measured levels of growth factors and vitamins in autologous serum eye drops before and after filtration, to see if filtering reduces their concentration. The goal is…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Scientists uncover immune cell clues in rare scleroderma
Knowledge-focused CompletedThis study looked at 235 people to understand how certain immune cells, called innate T cells, might be involved in systemic sclerosis (a rare disease that causes hardening of the skin and organs). Researchers compared patients with systemic sclerosis to those with other autoimmu…
Phase: NA • Sponsor: Poitiers University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Gut clues could unlock Sjogren's mystery
Knowledge-focused CompletedThis study looked at whether immune cells from the intestine play a role in Sjogren's syndrome, an autoimmune disease that causes dry eyes and mouth. Researchers examined saliva gland samples from 57 adults suspected of having Sjogren's. The goal was to better understand the dise…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Scientists investigate immune cell role in rare IgG4 disease
Knowledge-focused CompletedThis study looked at a rare disease called IgG4-related disease, which causes swelling and scarring in organs. Researchers compared immune cells in the blood of 75 people: those with the disease, those with Sjogren syndrome, and healthy volunteers. The goal was to better understa…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Food safety training put to the test: do workers learn better habits?
Knowledge-focused CompletedThis study looked at whether a food safety training program helps food service employees improve their knowledge, attitudes, and practices around safe food handling. About 200 adult workers took part, and the training covered personal hygiene and safe food preparation. The goal w…
Phase: NA • Sponsor: Kayseri University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Eczema drug Tralokinumab's eye risks under the microscope
Knowledge-focused CompletedThis study looked at 100 adults with atopic dermatitis (eczema) who were prescribed tralokinumab. Researchers tracked how many developed eye problems like conjunctivitis within 4 months of starting the drug. The goal was to better understand these side effects in real-world use, …
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Hidden gut troubles in Sjögren's patients revealed
Knowledge-focused CompletedThis study looked at how often people with primary Sjögren's syndrome have digestive issues. Researchers asked 151 patients about 10 different digestive symptoms using a simple questionnaire. The goal was to understand which symptoms are most common and how they relate to how lon…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Scientists decode DNA of rare eye tumors to track Cancer's moves
Knowledge-focused CompletedThis study looked at the DNA changes (mutations) in eye cancers called ocular melanoma. Researchers analyzed tumor samples from 58 patients to understand how these cancers develop and spread. The goal was to identify key mutations that could lead to better treatments in the futur…
Sponsor: The Wellcome Sanger Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
COVID-19's hidden toll on autoimmune patients revealed
Knowledge-focused CompletedThis study followed 293 people with autoimmune diseases and healthy volunteers to see how COVID-19 infection or vaccination affects their immune system, inflammation, and blood vessels. Participants were grouped based on their COVID-19 history and had up to 5 visits over 12-18 mo…
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Simple eye test could predict nerve damage in dry eye sufferers
Knowledge-focused CompletedThis completed study looked at 31 people with dry eye to see if measuring corneal sensitivity (how well the eye feels touch) can detect early-stage neurotrophic keratopathy, a condition where the cornea loses sensation. Researchers aimed to find out which dry eye patients might l…
Phase: NA • Sponsor: Research Insight LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Immune clues in rare lung disease explored
Knowledge-focused CompletedThis completed study looked at how the immune system might affect the outlook for people with pulmonary arterial hypertension (PAH). Researchers took blood and skin samples from 629 participants with different types of PAH to search for specific antibodies. The goal was to better…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
How many autoimmune patients try alternative therapies? new study counts
Knowledge-focused CompletedThis completed study surveyed 121 adults with autoimmune diseases like lupus, Sjögren's syndrome, or scleroderma. Participants filled out a questionnaire about their use of alternative medicines. The goal was to find out how common these practices are in this patient group.
Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New digital tool could make eye scar assessment more accurate
Knowledge-focused CompletedThis study tested a digital color scale to objectively measure scarring of the eye's surface in people with recurrent pterygium, a growth that can come back after surgery. Researchers took photos of 25 patients' eyes and used software to analyze the scar tissue. The goal was to s…
Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Hidden struggles: study reveals psychological burden of thyroid eye disease
Knowledge-focused CompletedThis completed study from Thomas Jefferson University involved 20 adults with thyroid eye disease and their caregivers. Researchers conducted focus groups and interviews to understand how the condition affects mood, relationships, work, and daily life. Participants also completed…
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
PCOS drugs may change your eyes – new study reveals
Knowledge-focused CompletedThis study examined how common PCOS treatments (birth control pills and clomiphene citrate) affect the eyes. Researchers measured dry eye signs and retinal blood vessels in 60 women with PCOS and compared them to 30 healthy women. The goal was to see if these treatments cause cha…
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Eye Surgery's hidden impact on blood flow revealed
Knowledge-focused CompletedThis study looked at how a surgery called balanced orbital decompression affects blood flow in the eyes of people with inactive thyroid-associated orbitopathy (thyroid eye disease). Researchers measured blood vessel changes in the eye before and after surgery using special imagin…
Phase: NA • Sponsor: Marmara University Pendik Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Eye scans reveal hidden blood vessel changes in thyroid disease patients
Knowledge-focused CompletedThis completed study looked at 68 adults with thyroid-associated orbitopathy (thyroid eye disease) to see how changes in the eye socket affect blood vessels in the retina. Using a special imaging technique called OCTA, researchers measured vessel density in different layers of th…
Sponsor: Osijek University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Can a single nurse monitor multiple eye surgeries safely?
Knowledge-focused CompletedThis study looked at whether a central monitoring station outside the operating room could safely replace having an anesthesia nurse in each room during eye surgeries like cataract removal. Researchers compared the rate of complications (like high blood pressure or low oxygen) be…
Phase: NA • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
No-Stitch eye surgery shows promise for pterygium patients
Knowledge-focused CompletedThis study looked at two methods for fixing a tissue graft after removing a pterygium, a growth on the eye's surface. In 30 patients with pterygium in both eyes, one eye received stitches and the other did not. Researchers used special imaging to compare healing, comfort, and gra…
Phase: NA • Sponsor: Minia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Exercise program shows promise for rheumatic pain and mood
Knowledge-focused CompletedThis study looked at how a special exercise approach called BETY affects people with rheumatic diseases (like arthritis) who have chronic pain. Researchers reviewed past records of 300 participants to see if BETY improved their physical function, mood, and quality of life compare…
Phase: NA • Sponsor: Eastern Mediterranean University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
New study checks if pelvic floor survey works for Sjögren's patients
Knowledge-focused CompletedThis study looked at whether a pelvic floor symptom questionnaire (PFDI-20) is valid and reliable for people with primary Sjögren's syndrome. Ten adults with the condition completed the survey along with other health assessments. The goal was to see if the questionnaire accuratel…
Sponsor: Pamukkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Sjögren's patients face hidden jaw pain, new study reveals
Knowledge-focused CompletedThis study looked at 27 adults with Sjögren's syndrome to find out how common jaw joint problems (TMD) are and if they relate to disease activity. Researchers measured jaw function, mouth opening, head posture, and oral health. The goal was to better understand the link between S…
Sponsor: Pamukkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Could a single DNA test solve the mystery of rare brain diseases in kids?
Knowledge-focused CompletedThis study looked at whether whole genome sequencing (a complete read of a person's DNA) can help diagnose leukodystrophies, a group of rare brain diseases that are hard to identify. Researchers enrolled 236 children with white matter abnormalities on brain scans but no known gen…
Sponsor: Children's Hospital of Philadelphia • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Autoimmune disease and C-Section: new study targets bleeding risks
Knowledge-focused CompletedThis completed study looked at 1,000 women with autoimmune diseases (like lupus) who had a C-section. Researchers wanted to find out how many had severe bleeding (postpartum hemorrhage) and what factors increased that risk. By analyzing medical records, they hope to identify high…
Sponsor: RenJi Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Blood cell counts may reveal clues about autoimmune diseases
Knowledge-focused CompletedThis study looked at specific cells in the blood of 40 women with either Sjögren's syndrome or systemic sclerosis. The goal was to see if counting these cells could help understand the diseases better. No treatment was given; it was purely an observational study to explore potent…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Eye drop study reveals hidden link between bacteria and dry eye relief
Knowledge-focused CompletedThis completed study looked at how two types of eye drops—cyclosporine A and hyaluronic acid—change the community of bacteria living on the eye's surface in people with dry eye syndrome. Fifty adults were randomly assigned to receive either cyclosporine plus hyaluronic acid or hy…
Phase: NA • Sponsor: Hallym University Kangnam Sacred Heart Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:13 UTC